Evidence map›Paper›PMID 27983520›Full record

ArticlePhysics in medicine and biology2017

Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.

Neelam Tyagi, Sandra Fontenla, Jing Zhang, Michelle Cloutier, Mo Kadbi, Jim Mechalakos, Michael Zelefsky, Joe Deasy, Margie Hunt

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Physics in medicine and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Quality evaluation of synthetic CT using a gamma analysis for prostate cancer MR-only radiotherapy.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Neelam TyagiDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Sandra FontenlaDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Jing ZhangDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Michelle CloutierDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Mo KadbiPhilips Healthcare, 595 Milner Road, Cleveland, OH 44143, United States of America.
Jim MechalakosDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Michael ZelefskyDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Joe DeasyDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Margie HuntDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10065, United States of America.
Memorial Sloan Kettering Cancer Center · USPhilips (United States) · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

To evaluate a commercial synthetic CT (syn-CT) software for use in prostate radiotherapy. Twenty-five prostate patients underwent CT and MR simulation scans in treatment position on a 3T MR scanner. A commercially available MR protocol was used that included a T2w turbo spin-echo sequence for soft-tissue contrast and a dual echo 3D mDIXON fast field echo (FFE) sequence for generating syn-CT. A dual-echo 3D FFE B

Indexed as

Fiducial MarkersSoftwareBone and BonesHumansMalePelvic NeoplasmsProstatic NeoplasmsRadiotherapy, Image-GuidedRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedWorkflow

Identifiers

PMID27983520
PMCPMC5541676
OpenAlexW2563414858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.